Bristol-Myers Squibb Company (NYSE: BMY) stock closed at 79.98 per share at the end of the most recent trading day (a 1.29% change compared to the prior day closing price) with a volume of 10.45M shares and market capitalization of 170.28B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 30250 people. Bristol-Myers Squibb Company CEO is Giovanni Caforio.

The one-year performance of Bristol-Myers Squibb Company stock is 18.31%, while year-to-date (YTD) performance is 28.28%. BMY stock has a five-year performance of 43.15%. Its 52-week range is between 53.22 and 79, which gives BMY stock a 52-week price range ratio of 103.80%

Bristol-Myers Squibb Company currently has a PE ratio of 26.20, a price-to-book (PB) ratio of 4.97, a price-to-sale (PS) ratio of 3.34, a price to cashflow ratio of 10.10, a PEG ratio of 2.32, a ROA of 5.80%, a ROC of 9.09% and a ROE of 18.07%. The company’s profit margin is 13.35%, its EBITDA margin is 40.80%, and its revenue ttm is $46.96 Billion , which makes it $22.06 revenue per share.

Of the last four earnings reports from Bristol-Myers Squibb Company, there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.90 for the next earnings report. Bristol-Myers Squibb Company’s next earnings report date is 27th Jul 2022.

The consensus rating of Wall Street analysts for Bristol-Myers Squibb Company is Moderate Buy (2.15), with a target price of $78.18, which is -2.25% compared to the current price. The earnings rating for Bristol-Myers Squibb Company stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Bristol-Myers Squibb Company has a dividend yield of 2.93% with a dividend per share of $2.16 and a payout ratio of 273.00%.

Bristol-Myers Squibb Company has a Buy technical analysis rating based on Technical Indicators (ADX : 5.10, ATR14 : 1.50, CCI20 : 166.35, Chaikin Money Flow : 0.16, MACD : 0.23, Money Flow Index : 66.61, ROC : 3.09, RSI : 65.84, STOCH (14,3) : 99.45, STOCH RSI : 1.00, UO : 65.39, Williams %R : -0.55), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Bristol-Myers Squibb Company in the last 12-months were: Adam Dubow (Sold 2 466 shares of value $167 441 ), Christopher S. Boerner (Option Excercise at a value of $0), Christopher S. Boerner (Sold 29 532 shares of value $2 043 525 ), David V. Elkins (Option Excercise at a value of $3 394 299), David V. Elkins (Sold 99 691 shares of value $6 674 497 ), Elizabeth A. Mily (Option Excercise at a value of $0), Giovanni Caforio (Option Excercise at a value of $0), Giovanni Caforio (Sold 150 000 shares of value $10 278 400 ), Julia A. Haller (Option Excercise at a value of $0), Karen Murphy Santiago (Option Excercise at a value of $0), Karen Murphy Santiago (Sold 6 577 shares of value $455 096 ), Paul von Autenried (Sold 76 134 shares of value $4 624 992 ), Powell Ann Judge (Option Excercise at a value of $0), Powell Ann Judge (Sold 23 280 shares of value $1 596 309 ), Rupert Vessey (Option Excercise at a value of $10 764 377), Rupert Vessey (Sold 232 952 shares of value $15 945 125 ), Samit Hirawat (Option Excercise at a value of $0), Sandra Leung (Option Excercise at a value of $0), Sandra Leung (Sold 94 390 shares of value $6 867 545 )